Showing results (2121-2130 of 2,235) with videos related to

Sort By:
Pageof 224
The Journal of Clinical Investigation|January 17, 2014
Prion disease tempo determined by host-dependent substrate reductionCharles E Mays, Chae Kim, Tracy Haldiman, et al.
Pharmaceutics|July 27, 2022
Chalcones as Anti-Glioblastoma Stem Cell Agent Alone or as Nanoparticle Formulation Using Carbon Dots as NanocarrierEduardo A Veliz, Anastasiia Kaplina, Sajini D Hettiarachchi, et al.
Ophthalmology and Therapy|July 27, 2022
Management of Diabetic Macular Edema: Guidelines from the Emirates Society of OphthalmologyNoura Al Qassimi, Igor Kozak, Maysoon Al Karam, et al.
Oncotarget|November 22, 2017
Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CTCédric Rossi, Morgane Mounier, Pauline Brice, et al.
Diagnostics (Basel, Switzerland)|June 12, 2026
Exploratory Evaluation of Combined RENAL Nephrometry and Mayo Adhesive Probability Scores for Perioperative Outcomes in Radical NephrectomyMahdi Alayyafi, Omar Safar, Adel Elatreisy, et al.
Archives of Cardiovascular Diseases|August 12, 2023
Multicentre medicoeconomic evaluation of cardiac magnetic resonance imaging for predicting coronary artery disease in left ventricular dysfunction: The CAMAREC study designLouis-Marie Desroche, Damien Mandry, Gregory Ducrocq, et al.
Annals of Hematology|October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphomaEmilie Fargier, Florence Ranchon, Laure Huot, et al.
Plos Pathogens|June 13, 2025
Structural exposure of different microtubule binding domains determines the propagation and toxicity of pathogenic tau conformers in Alzheimer's diseaseLenka Hromadkova, Chae Kim, Tracy Haldiman, et al.
Journal of Assisted Reproduction and Genetics|February 11, 2025
Novel STAG3 variant causes oligoasthenoteratozoospermia with high sperm aneuploidy ratePolina N Tsabai, Nadezhda S Pavlova, Taras V Shatylko, et al.
Blood Advances|November 8, 2021
Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort dataLaurie H Sehn, Mark Hertzberg, Stephen Opat, et al.
Pageof 224